GeneDx Holdings Corp. (WGS)

SEC filing

GeneDx Holdings Corp.

WGS · CIK 1818331

4 · Jun 18, 2026 · Stueland Katherine sold 10.50K shares at $60.77/share ($638.1K); exercised options for 18.75K shares

Stueland Katherine sold 10.50K shares at $60.77/share ($638.1K); exercised options for 18.75K shares

xslF345X06/form4-06182026_080658.xml

xslF345X06/form4-06182026_080658.xmlSEC.gov

Graphics and non-inline formats (not embedded below).